ArticlePloS one2026
US healthcare professionals' knowledge, attitudes, and practices regarding RSV disease and vaccination in adults during the 2024-2025 RSV season.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Healthcare resource use and costs following RSV-related hospitalizations among US adults aged 50 years and older.Human vaccines & immunotherapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdults aged ≥60 years and adults with certain chronic medical conditions are at increased risk for severe respiratory syncytial virus (RSV) disease. However, RSV vaccine uptake in the United States (US) remains low, with limited awareness of RSV among adults and potential knowledge gaps among healthcare professionals (HCPs). This study assessed US HCP knowledge, attitudes, and practices (KAP) related to RSV disease and vaccination.
methodsA cross-sectional, web-based survey was administered among 700 HCPs, including primary care physicians (PCPs), specialist physicians, nurse practitioners (NPs) and physician assistants (PAs), and pharmacists, between December 2024-January 2025. Survey questions assessed RSV disease- and vaccination-related KAP, with descriptive statistics calculated overall and by HCP type. Characteristics associated with RSV-related KAP were identified through multivariable logistic regression modeling.
resultsAmong the 700 respondents (199 PCPs, 153 specialist physicians, 148 NPs and PAs, and 200 pharmacists), 72.3% reported being very familiar with RSV disease. However, potential knowledge gaps were identified (e.g., related to approved indications for RSV vaccines and Advisory Committee on Immunization Practices [ACIP] recommendations). HCPs commonly cited patients' refusal or hesitation (62.3%) and patients' lack of awareness of RSV (58.0%) as barriers to recommending and administering RSV vaccines. Although only 36.4% of HCPs reported that their workplace stocked RSV vaccine(s), 84.1% reported recommending RSV vaccines to eligible adult patients. However, RSV vaccination recommendations were not consistently implemented among all eligible adult patients. In multivariable modeling, characteristics that were significantly associated with RSV vaccination practices included familiarity with RSV disease, knowledge of ACIP recommendations, RSV vaccine stocking, and use of clinical decision supports, among other characteristics.
conclusionsPotential knowledge- and practice-related gaps remain regarding adult RSV disease and vaccination among US HCPs. Continued efforts are needed to enhance RSV-related education among HCPs and ensure eligible patients are able to access RSV vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.